IOSCO seeks improved oversight of OTC markets
Review finds challenges monitoring OTC commodity derivatives
- By: James Langton
- November 25, 2024 November 25, 2024
- 14:06
Review finds challenges monitoring OTC commodity derivatives
Bond mutual fund sales increase, equity funds power ETF net sales
Shareholders to get $32 per share in cash, a 33% premium relative to the last closing price
Enforcement case volumes decline in fiscal 2024, agency says
Rep arranged a loan from one client to another to repay a "gang" debt
Research suggests looking to FX markets for solutions
Charges involve alleged bribes paid for government contracts in India
S&P 500 will fall to 4,100, Canada will also see a recession, Peter Berezin forecasts
RBC still requires the credential in retail branches, FSRA provides date for forthcoming title protection review
Here's how advisors can prevent AI hallucinations, privacy breaches
Economists predict that U.S. mortgage rates will hover around 6% in 2025
The broad plan is meant to lift wages, spur growth in the world's fourth largest economy
Chip, software companies up as 'bargain hunters' step in
Rents are still 12.9% higher than levels seen before the Covid pandemic
They rose 2.3% in 2025, while business insolvencies fell by 21.8%
Unique provision aims to balance interests, provide greater certainty
Agency seeks feedback on new due diligence standards, enforcement
Regulators flag retail investor issues, market structure, resilience for 2026
187 mutual funds, 117 ETFs and 114 seg funds were recognized
GoSmart targets newer investors, excludes mutual funds, GICs, bonds, options
Plus, GreenShield buys Kii Health's Canadian mental health services segment
Plus, moves at Our Family Office, Harvest ETFs, Manulife Wealth, Canada Life and more
Plus, Wellington-Alus Private Counsel and Ninepoint Partners add new talent
Also, moves at Mackenzie Investments, Edward Jones Canada and the CSA
Plus, National Bank changes diversified equity fund
Net monthly ETF inflows reach $22B in January: report
Plus, other firms launch new products, tweak their fund lineups